1. Home
  2. DUOL vs ITCI Comparison

DUOL vs ITCI Comparison

Compare DUOL & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DUOL
  • ITCI
  • Stock Information
  • Founded
  • DUOL 2011
  • ITCI 2002
  • Country
  • DUOL United States
  • ITCI United States
  • Employees
  • DUOL N/A
  • ITCI N/A
  • Industry
  • DUOL Computer Software: Prepackaged Software
  • ITCI Biotechnology: Pharmaceutical Preparations
  • Sector
  • DUOL Technology
  • ITCI Health Care
  • Exchange
  • DUOL Nasdaq
  • ITCI Nasdaq
  • Market Cap
  • DUOL 14.9B
  • ITCI 13.5B
  • IPO Year
  • DUOL 2021
  • ITCI N/A
  • Fundamental
  • Price
  • DUOL $315.00
  • ITCI $131.81
  • Analyst Decision
  • DUOL Buy
  • ITCI Buy
  • Analyst Count
  • DUOL 13
  • ITCI 13
  • Target Price
  • DUOL $387.27
  • ITCI $106.58
  • AVG Volume (30 Days)
  • DUOL 1.0M
  • ITCI 2.0M
  • Earning Date
  • DUOL 05-07-2025
  • ITCI 05-06-2025
  • Dividend Yield
  • DUOL N/A
  • ITCI N/A
  • EPS Growth
  • DUOL 437.14
  • ITCI N/A
  • EPS
  • DUOL 1.88
  • ITCI N/A
  • Revenue
  • DUOL $748,024,000.00
  • ITCI $680,852,000.00
  • Revenue This Year
  • DUOL $32.71
  • ITCI $40.64
  • Revenue Next Year
  • DUOL $25.82
  • ITCI $58.53
  • P/E Ratio
  • DUOL $167.55
  • ITCI N/A
  • Revenue Growth
  • DUOL 40.84
  • ITCI 46.62
  • 52 Week Low
  • DUOL $145.05
  • ITCI $64.09
  • 52 Week High
  • DUOL $441.77
  • ITCI $131.87
  • Technical
  • Relative Strength Index (RSI)
  • DUOL 47.31
  • ITCI 85.59
  • Support Level
  • DUOL $323.43
  • ITCI $131.19
  • Resistance Level
  • DUOL $341.75
  • ITCI $131.79
  • Average True Range (ATR)
  • DUOL 16.77
  • ITCI 0.13
  • MACD
  • DUOL 6.38
  • ITCI -0.41
  • Stochastic Oscillator
  • DUOL 63.00
  • ITCI 91.18

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include The Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has three predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test.

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Share on Social Networks: